IPP Bureau
Merck’s KEYTRUDA bags FDA nod for platinum-resistant ovarian cancer
By IPP Bureau - February 13, 2026
KEYTRUDA QLEX is contraindicated in patients with known hypersensitivity to its components
Merck KGaA’s Belen Garijo to become CEO of Sanofi
By IPP Bureau - February 13, 2026
Garijo will be the first woman to lead Sanofi in its history
DFE Pharma launches EcoLact 2030 to deliver verified CO2 cuts across pharma supply chains
By IPP Bureau - February 13, 2026
The program provides pharmaceutical manufacturers with auditable, primary emissions data and verified proof of a 30% CO? reduction across DFE Pharma’s lactose portfolio
Biocon posts strong Q3FY26 growth, boosted by biosimilars & generics
By IPP Bureau - February 13, 2026
Profit before tax jumped 64% to Rs. 226 crore, while the company maintained robust investment in innovation with net R&D spend of Rs. 249 crore
Supriya Lifescience delivers robust Q3 FY26 performance with 11% YoY revenue growth
By IPP Bureau - February 13, 2026
The Profit After Tax (PAT) for Q3 FY26 was Rs 49.68 crore, compared to Rs 46.78 crore in Q3 FY25
Lupin Q3 FY26 consolidated PAT jumped 37.4% to Rs. 1,180.5 Cr
By IPP Bureau - February 13, 2026
U.S. market achieved record quarterly sales of Rs. 3,113.2 crore ($350 million), a 54% YoY increase, accounting for 44% of global sales
Alkem MedTech to acquire 55% stake in Switzerland's Occlutech for €99.4M
By IPP Bureau - February 13, 2026
Occlutech develops, manufactures, and commercialises medical devices for congenital heart disease, stroke prevention, and heart failure
Moderna signs five-year strategic mRNA vaccine pact with Mexico
By IPP Bureau - February 12, 2026
Signed Memorandum of Understanding supports "Plan Mexico," Mexico's strategic initiative to build a local mRNA ecosystem and strengthen health security
Aurobindo Pharma reports strong Q3 FY26 performance, boosted by Europe & ARV growth
By IPP Bureau - February 12, 2026
Hikal Q3 FY26: Revenue, EBITDA surge amid regulatory recovery
By IPP Bureau - February 12, 2026
The pharmaceutical segment led growth, generating Rs. 337 crore in revenue, while the crop protection business contributed Rs. 157 crore
Syngene collaborates with Johns Hopkins University to advance early-stage drug discovery
By IPP Bureau - February 11, 2026
The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
Wockhardt reports strong Q3 growth: revenue up 22%, EBITDA surges 72%
By IPP Bureau - February 11, 2026
The company reported profit before tax of Rs.67 crore, up sharply from Rs.21 crore in the same period last year
Apollo Hospitals reports robust Q3 earnings; profit after tax humps to Rs. 3,835 million
By IPP Bureau - February 11, 2026
Revenue from operations rose to Rs. 23,637 million for the three months ended December 31, 2025
Iambic taps AI to power multi-year drug discovery deal with Takeda
By IPP Bureau - February 11, 2026
Veradermics completes enrollment in both Phase 3 male hair loss trials
By IPP Bureau - February 11, 2026
The milestone means more than 1,000 men are now enrolled across both Phase 3 programs
